| Literature DB >> 35415001 |
Matthieu Chourrout1,2, Hugo Rositi3,2, Elodie Ong4,5, Violaine Hubert4, Alexandre Paccalet4, Louis Foucault6, Awen Autret7, Barbara Fayard7, Cécile Olivier8, Radu Bolbos9, Françoise Peyrin8, Claire Crola-da-Silva4, David Meyronet5, Olivier Raineteau6, Héléne Elleaume10, Emmanuel Brun10, Fabien Chauveau1,11,12, Marlene Wiart4,11,12.
Abstract
White-matter injury leads to severe functional loss in many neurological diseases. Myelin staining on histological samples is the most common technique to investigate white-matter fibers. However, tissue processing and sectioning may affect the reliability of 3D volumetric assessments. The purpose of this study was to propose an approach that enables myelin fibers to be mapped in the whole rodent brain with microscopic resolution and without the need for strenuous staining. With this aim, we coupled in-line (propagation-based) X-ray phase-contrast tomography (XPCT) to ethanol-induced brain sample dehydration. We here provide the proof-of-concept that this approach enhances myelinated axons in rodent and human brain tissue. In addition, we demonstrated that white-matter injuries could be detected and quantified with this approach, using three animal models: ischemic stroke, premature birth and multiple sclerosis. Furthermore, in analogy to diffusion tensor imaging (DTI), we retrieved fiber directions and DTI-like diffusion metrics from our XPCT data to quantitatively characterize white-matter microstructure. Finally, we showed that this non-destructive approach was compatible with subsequent complementary brain sample analysis by conventional histology. In-line XPCT might thus become a novel gold-standard for investigating white-matter injury in the intact brain. This is Part I of a series of two articles reporting the value of in-line XPCT for virtual histology of the brain; Part II shows how in-line XPCT enables the whole-brain 3D morphometric analysis of amyloid- β (A β ) plaques.Entities:
Year: 2022 PMID: 35415001 PMCID: PMC8973191 DOI: 10.1364/BOE.438832
Source DB: PubMed Journal: Biomed Opt Express ISSN: 2156-7085 Impact factor: 3.732